Clinical trials recruiting for Cardiogenic Shock
25
Recruiting trials
14
US states with sites
16
Countries
0%
Accept healthy volunteers
Phase breakdown
Early Phase 1 1Phase 2 1Phase 3 2Phase 4 1Not applicable 20
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 1:1 Randomization to receive milrinone | 1 |
| Bivalirudin | 1 |
| Empagliflozin 10 MG | 1 |
| Heparin | 1 |
| Inotrope | 1 |
| Ketone Monoester (KE) | 1 |
| Levosimendan 2.5 MG/ML Injectable Solution | 1 |
| Vasopressor | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 3 |
| Illinois | 2 |
| New York | 2 |
| Texas | 2 |
| Virginia | 2 |
| Washington | 2 |
| California | 1 |
| Florida | 1 |
| Maine | 1 |
| Minnesota | 1 |
| New Jersey | 1 |
| North Carolina | 1 |
Top cities
Boston, Massachusetts 3Chicago, Illinois 2Dallas, Texas 2Falls Church, Virginia 2New York, New York 2Seattle, Washington 2Durham, North Carolina 1Galveston, Texas 1Hackensack, New Jersey 1Houston, Texas 1
Self-screener
Recruiting trials
- Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
- BEAT-SHOCK Registry
- COMPARE-VENT Feasibility Pilot Study
- Cardiac Power Output in Cardiogenic Shock Patients
- Cardiogenic Shock Working Group Registry
- Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
- Characterisation of phenotYpes in aCute Heart faiLure patiEnts
- China Extracorporeal Life Support Registry
- CytOSorb TreatMent Of Critically Ill PatientS Registry
- Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
- Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
- Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients
- Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial
- Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
- Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
- Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
- Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)
- Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock
- Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
- Pulmonary Artery Catheter in Cardiogenic Shock Trial
- Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
- Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure
- Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease
- Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
Related conditions
Trials recruiting for Cardiogenic Shock often also study these conditions. Each links to its own recruiting-trial list.
Heart failure 1021Acute Heart Failure (AHF) 18Septic Shock 6Acute Respiratory Distress Syndrome 4Acute Myocardial Infarction 7Acute Heart Failure 24Acute Decompensated Heart Failure 16Trauma 11Sepsis 6Percutaneous Coronary Intervention 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cardiogenic Shock trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.